“50 in 10”
In October 2016, Susan G. Komen announced a Bold Goal. Komen is committed to reducing the current number of breast cancer deaths by 50 percent in the U.S. by the year 2026.
Despite tremendous progress against this disease, more than 40,000 women and men still die of breast cancer every year in the United States.
We can do better.
We will do so by drawing on our unparalleled leadership in research and advocacy, and by working to ensure that every person has access to, and receives, timely high-quality breast cancer care. This is Susan G. Komen’s new direction.
This is our Bold Goal.
We are bringing a heightened focus to our strategic objectives, so that we will more quickly achieve our vision of a world without breast cancer. This is our promise to all people facing breast cancer.
Most breast cancer deaths occur because we lack effective treatment for the disease. We will get the necessary, effective treatments by improving our understanding of the biology of breast cancer through basic research, and by applying this biology to develop treatments for lethal forms of breast cancer. Our Bold Goal sets an enhanced emphasis on finding new treatments for aggressive and incurable forms of breast cancer by leveraging Komen’s expertise in identifying and funding the best and most innovative breast cancer research and researchers.
This work has already begun: more than 60 percent of our 2016 research grant portfolio was invested in these areas, including:
- Metastatic breast cancer research
- New treatments for aggressive types of breast cancer
- New technologies to detect new or recurrent breast cancer
- Understanding factors in disparities
We know that research is critical to ending breast cancer. But we have also learned over three-and-a-half decades that all the research in the world won’t help if its benefits don’t reach the women and men who need it. Today, too many people die because of financial, socioeconomic, geographic and cultural barriers to high-quality breast cancer care.
Komen has always believed that where you live should not determine whether you live. For decades, Komen and its network of local Affiliates has worked to level the playing field for medically underserved populations.
Community grantees funded by Komen and its Affiliates provide breast cancer screenings, diagnostic tests, medical supplies, out-of-pocket medical costs, surgeries and other therapies, transportation to treatment, culturally sensitive education, patient navigation programs – even emergency living expenses. We fund such programs because they are critical and because some, such as patient navigation programs, are proven to improve five-year survival rates of breast cancer patients who were navigated from screening through resolution.
In our first 35 years, Komen’s work has saved lives and changed the culture.
We brought breast cancer out of the shadows.
We gave women a voice.
With our Susan G. Komen Race for the Cure, we built a global community of women and men, millions strong, running and walking on four continents to end breast cancer, forever.
Our community made it possible for Komen to invest almost $3 billion in research, community, global, and advocacy programs that have helped millions. Our journey today will be faster and deeper. We will reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026.
This is our Bold Goal. Please join us.
Learn more about the Bold Goal